SODIUM BICARBONATE INJECTION,

SODIUM BICARBONATE INJECTION, was reported 23578 times

SODIUM BICARBONATE INJECTION, is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 27 0.9000
1 FOETAL BIOPHYSICAL PROFILE SCORE ABNORMAL 19 0.6129
2 CENTRAL NERVOUS SYSTEM MASS 44 0.4632
3 VAGINAL FLATULENCE 132 0.4356
4 WALL MOTION SCORE INDEX ABNORMAL 45 0.4091
5 AIRWAY REMODELLING 44 0.3548
6 VENA CAVA INJURY 28 0.3043
7 PERINEAL CYST 22 0.3014
8 ANTACID THERAPY 38 0.2923
9 SLEEP DISORDER THERAPY 54 0.2727
10 APPENDICOLITH 77 0.1990
11 RENAL CYST HAEMORRHAGE 40 0.1770
12 SENSITISATION 134 0.1765
13 EJECTION FRACTION 101 0.1738
14 ANALGESIC THERAPY 52 0.1620
15 ATOPY 44 0.1583
16 DRUG THERAPY 46 0.1357
17 ANTICOAGULANT THERAPY 37 0.1303
18 IRON BINDING CAPACITY TOTAL DECREASED 26 0.1176
19 CONGENITAL HIATUS HERNIA 22 0.0965
20 ABDOMINAL WALL HAEMORRHAGE 24 0.0920
21 MALIGNANT MELANOMA STAGE 0 19 0.0909
22 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 27 0.0891
23 POLYCYSTIC OVARIES 131 0.0844
24 FEMALE GENITAL TRACT FISTULA 142 0.0831
25 DELAYED GRAFT FUNCTION 58 0.0816
26 BACTEROIDES INFECTION 21 0.0805
27 VASCULAR COMPRESSION 25 0.0791
28 HYPERPARATHYROIDISM SECONDARY 192 0.0766
29 CARBUNCLE 21 0.0742
30 EJECTION FRACTION ABNORMAL 74 0.0604
31 EOSINOPHILIC MYOCARDITIS 44 0.0603
32 NEPHROGENIC ANAEMIA 274 0.0591
33 CARDIAC SEPTAL DEFECT 42 0.0584
34 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 61 0.0574
35 RADICULOPATHY 145 0.0550
36 HYPERPHOSPHATAEMIA 118 0.0548
37 CHRONIC SINUSITIS 201 0.0535
38 BLOOD PHOSPHORUS INCREASED 133 0.0487
39 METABOLIC ALKALOSIS 77 0.0480
40 MICROANGIOPATHY 45 0.0479
41 PROCTITIS 134 0.0478
42 ALKALOSIS 18 0.0471
43 DRUG CLEARANCE DECREASED 60 0.0459
44 ANION GAP 27 0.0426
45 RENAL ARTERY STENOSIS 54 0.0392
46 OBSTRUCTIVE SLEEP APNOEA SYNDROME 57 0.0391
47 INCISION SITE PAIN 45 0.0383
48 RED BLOOD CELLS URINE POSITIVE 37 0.0383
49 CAROTID ARTERIOSCLEROSIS 39 0.0378
50 NEPHRECTOMY 54 0.0363
51 INTERVERTEBRAL DISC SPACE NARROWING 29 0.0360
52 BLOOD ALKALINE PHOSPHATASE DECREASED 32 0.0337
53 AORTIC DILATATION 37 0.0333
54 RHINITIS ALLERGIC 145 0.0325
55 WRIST DEFORMITY 20 0.0325
56 CRYSTAL NEPHROPATHY 18 0.0304
57 MONOCLONAL IMMUNOGLOBULIN PRESENT 23 0.0303
58 RECTAL PROLAPSE 36 0.0298
59 END STAGE RENAL DISEASE 530 0.0290
60 HYPERCHLORAEMIA 18 0.0281
61 CARBON DIOXIDE DECREASED 32 0.0278
62 SUPERFICIAL VEIN THROMBOSIS 23 0.0273
63 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 25 0.0270
64 COMPLICATIONS OF TRANSPLANTED KIDNEY 61 0.0269
65 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 129 0.0255
66 TOTAL LUNG CAPACITY DECREASED 40 0.0250
67 RESPIRATORY SYMPTOM 66 0.0232
68 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 118 0.0230
69 MACULAR DEGENERATION 274 0.0229
70 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 45 0.0220
71 BLOOD CHLORIDE INCREASED 38 0.0220
72 HYPERURICAEMIA 88 0.0214
73 MEAN CELL VOLUME INCREASED 54 0.0210
74 RENAL TUBULAR ACIDOSIS 45 0.0206
75 EOSINOPHIL COUNT DECREASED 49 0.0206
76 BLOOD IMMUNOGLOBULIN E INCREASED 48 0.0198
77 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 21 0.0198
78 FOETAL HEART RATE ABNORMAL 18 0.0194
79 AORTIC STENOSIS 67 0.0192
80 RENAL ATROPHY 24 0.0192
81 BLOOD URIC ACID INCREASED 111 0.0192
82 RENAL TRANSPLANT 68 0.0188
83 LUNG OPACITY 49 0.0186
84 NEPHROGENIC SYSTEMIC FIBROSIS 56 0.0185
85 KIDNEY TRANSPLANT REJECTION 88 0.0183
86 AORTIC ARTERIOSCLEROSIS 47 0.0182
87 HYPOPROTEINAEMIA 34 0.0179
88 IRON DEFICIENCY 79 0.0175
89 HYPOPHOSPHATAEMIA 128 0.0173
90 METABOLIC ACIDOSIS 550 0.0172
91 VENTRICULAR HYPOKINESIA 55 0.0171
92 HYPOCHLORAEMIA 20 0.0171
93 ACUTE LUNG INJURY 20 0.0169
94 VENTRICULAR FIBRILLATION 187 0.0168
95 EOSINOPHILIC PNEUMONIA 52 0.0165
96 HYPERNATRAEMIA 82 0.0164
97 URETERIC OBSTRUCTION 22 0.0161
98 FANCONI SYNDROME ACQUIRED 28 0.0159
99 BLOOD BICARBONATE DECREASED 30 0.0158
100 ACTINIC KERATOSIS 41 0.0158
101 HYPOALBUMINAEMIA 121 0.0155
102 BICYTOPENIA 30 0.0153
103 HYPOTHALAMO-PITUITARY DISORDER 22 0.0151
104 LEFT VENTRICULAR HYPERTROPHY 64 0.0149
105 BLOOD POTASSIUM INCREASED 241 0.0148
106 HEPATOSPLENOMEGALY 38 0.0148
107 CALCIPHYLAXIS 27 0.0147
108 REBOUND ACID HYPERSECRETION 44 0.0145
109 ACIDOSIS 111 0.0145
110 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 23 0.0143
111 NEPHROPATHY 133 0.0142
112 CARDIOGENIC SHOCK 204 0.0142
113 PROTEIN URINE PRESENT 70 0.0140
114 BLOOD TEST ABNORMAL 197 0.0140
115 KIDNEY FIBROSIS 24 0.0138
116 ANION GAP INCREASED 18 0.0135
117 ORAL CANDIDIASIS 175 0.0133
118 HYPERVOLAEMIA 65 0.0131
119 RENAL FAILURE CHRONIC 101 0.0131
120 HYPERPARATHYROIDISM 27 0.0131
121 VAGINAL DISCHARGE 132 0.0130
122 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 43 0.0130
123 METHAEMOGLOBINAEMIA 30 0.0129
124 LYMPHOCYTE COUNT DECREASED 226 0.0128
125 BLOOD UREA INCREASED 214 0.0128
126 PARAESTHESIA ORAL 180 0.0125
127 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 32 0.0124
128 BLOOD PH DECREASED 21 0.0123
129 ACCIDENT AT WORK 27 0.0122
130 BENIGN PROSTATIC HYPERPLASIA 63 0.0122
131 HYPERKALAEMIA 422 0.0120
132 PULSELESS ELECTRICAL ACTIVITY 50 0.0120
133 PUPIL FIXED 20 0.0115
134 AZOTAEMIA 46 0.0115
135 CHRONIC KIDNEY DISEASE 875 0.0115
136 SPINAL STENOSIS 47 0.0114
137 FIBROSIS 35 0.0114
138 TUMOUR LYSIS SYNDROME 100 0.0114
139 MULTI-ORGAN FAILURE 196 0.0113
140 ACUTE KIDNEY INJURY 1735 0.0113
141 TOXIC EPIDERMAL NECROLYSIS 172 0.0113
142 RENAL TUBULAR NECROSIS 111 0.0113
143 DIVERTICULUM INTESTINAL 49 0.0112
144 SKIN INDURATION 23 0.0111
145 CARDIOVASCULAR INSUFFICIENCY 18 0.0110
146 RENAL INJURY 325 0.0109
147 PNEUMOPERITONEUM 20 0.0108
148 DIASTOLIC DYSFUNCTION 33 0.0107
149 BLOOD ALBUMIN DECREASED 84 0.0106
150 RENAL FAILURE 1400 0.0105
151 DIALYSIS 148 0.0104
152 CARPAL TUNNEL SYNDROME 145 0.0103
153 AORTIC VALVE INCOMPETENCE 44 0.0103
154 NEUTROPHIL COUNT INCREASED 105 0.0102
155 CLONUS 28 0.0102
156 BLOOD CREATININE INCREASED 665 0.0102
157 APLASIA PURE RED CELL 35 0.0102
158 BLOOD IMMUNOGLOBULIN G DECREASED 25 0.0101
159 EOSINOPHIL COUNT INCREASED 84 0.0101
160 ANHEDONIA 262 0.0100
161 ESSENTIAL HYPERTENSION 18 0.0098
162 APPENDICITIS 91 0.0097
163 HYPOVOLAEMIA 57 0.0097
164 ATRIOVENTRICULAR BLOCK FIRST DEGREE 42 0.0097
165 FEBRILE BONE MARROW APLASIA 41 0.0096
166 CEREBRAL HAEMATOMA 32 0.0095
167 MYASTHENIA GRAVIS 76 0.0094
168 HYPOCALCAEMIA 177 0.0093
169 NASAL POLYPS 46 0.0093
170 FINGER DEFORMITY 45 0.0093
171 DISTRIBUTIVE SHOCK 21 0.0093
172 TUBULOINTERSTITIAL NEPHRITIS 173 0.0092
173 HYDRONEPHROSIS 69 0.0092
174 HAEMODYNAMIC INSTABILITY 70 0.0092
175 FULL BLOOD COUNT ABNORMAL 97 0.0092
176 TROPONIN INCREASED 69 0.0091
177 VASCULAR DEVICE INFECTION 41 0.0090
178 HYPOKALAEMIA 417 0.0090
179 RENAL CYST 71 0.0089
180 HYPERLIPIDAEMIA 106 0.0089
181 LEFT VENTRICULAR FAILURE 30 0.0087
182 ATRIOVENTRICULAR BLOCK 67 0.0087
183 DYSLIPIDAEMIA 44 0.0087
184 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 19 0.0086
185 FEAR 232 0.0086
186 RENAL IMPAIRMENT 723 0.0086
187 BLOOD PARATHYROID HORMONE INCREASED 25 0.0086
188 HYPERLACTACIDAEMIA 23 0.0086
189 BILIRUBIN CONJUGATED INCREASED 20 0.0086
190 GLOMERULAR FILTRATION RATE DECREASED 104 0.0085
191 MULTIPLE ORGAN DYSFUNCTION SYNDROME 239 0.0084
192 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 143 0.0084
193 RENAL DISORDER 389 0.0083
194 METABOLIC ENCEPHALOPATHY 25 0.0083
195 CYTOMEGALOVIRUS COLITIS 19 0.0083
196 VENTRICULAR ARRHYTHMIA 30 0.0082
197 PROCEDURAL HAEMORRHAGE 32 0.0082
198 VENTRICULAR TACHYCARDIA 135 0.0082
199 SLEEP APNOEA SYNDROME 155 0.0081
200 BLOOD CALCIUM DECREASED 91 0.0081
201 INTESTINAL ISCHAEMIA 44 0.0080
202 VARICELLA 19 0.0079
203 SQUAMOUS CELL CARCINOMA OF SKIN 48 0.0079
204 RESPIRATORY ACIDOSIS 31 0.0079
205 PYELONEPHRITIS 68 0.0078
206 STAPHYLOCOCCAL BACTERAEMIA 34 0.0078
207 URINE OUTPUT DECREASED 68 0.0078
208 BRAIN DEATH 24 0.0078
209 ELECTROLYTE IMBALANCE 90 0.0077
210 TACHYARRHYTHMIA 19 0.0076
211 PLEURITIC PAIN 21 0.0076
212 PNEUMONIA FUNGAL 30 0.0076
213 COMA SCALE ABNORMAL 22 0.0076
214 BLOOD LACTIC ACID INCREASED 40 0.0076
215 SKIN HYPERTROPHY 21 0.0075
216 RENAL FAILURE ACUTE 314 0.0074
217 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 28 0.0073
218 EUGLYCAEMIC DIABETIC KETOACIDOSIS 30 0.0073
219 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 19 0.0072
220 HYPOTHYROIDISM 231 0.0072
221 BLOOD CREATINE INCREASED 32 0.0072
222 CARDIAC FAILURE ACUTE 48 0.0072
223 GOUT 129 0.0072
224 BLOOD CALCIUM INCREASED 63 0.0072
225 CYTOMEGALOVIRUS INFECTION 119 0.0072
226 BLOOD POTASSIUM ABNORMAL 19 0.0071
227 SINUS TACHYCARDIA 101 0.0071
228 BRAIN HERNIATION 21 0.0070
229 CYTOMEGALOVIRUS VIRAEMIA 31 0.0070
230 HYPOMAGNESAEMIA 97 0.0070
231 BLOOD CREATININE ABNORMAL 24 0.0069
232 OLIGURIA 43 0.0069
233 BREATH SOUNDS ABNORMAL 34 0.0069
234 LUNG CONSOLIDATION 19 0.0068
235 TRANSPLANT REJECTION 54 0.0067
236 FEBRILE NEUTROPENIA 447 0.0067
237 IMMUNE THROMBOCYTOPENIC PURPURA 19 0.0067
238 CYTOKINE RELEASE SYNDROME 134 0.0067
239 HYPERCAPNIA 20 0.0066
240 ASCITES 195 0.0066
241 HIGH DENSITY LIPOPROTEIN DECREASED 22 0.0066
242 BLOOD MAGNESIUM DECREASED 57 0.0066
243 BACTERAEMIA 78 0.0066
244 KLEBSIELLA INFECTION 33 0.0065
245 BK VIRUS INFECTION 22 0.0065
246 PROTEINURIA 124 0.0065
247 SPINAL OSTEOARTHRITIS 57 0.0065
248 RHINOVIRUS INFECTION 25 0.0064
249 FIBROMYALGIA 154 0.0063
250 HYPERREFLEXIA 22 0.0063
251 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 41 0.0063
252 PROCEDURAL PAIN 175 0.0063
253 CAROTID ARTERY STENOSIS 22 0.0063
254 LYMPHOPENIA 89 0.0063
255 HEPARIN-INDUCED THROMBOCYTOPENIA 31 0.0063
256 SERUM FERRITIN INCREASED 33 0.0063
257 SEPTIC SHOCK 271 0.0062
258 ASPIRATION 68 0.0062
259 ENTEROCOCCAL INFECTION 30 0.0062
260 FREQUENT BOWEL MOVEMENTS 167 0.0062
261 COAGULOPATHY 103 0.0062
262 ACUTE RESPIRATORY DISTRESS SYNDROME 109 0.0062
263 PERIPHERAL ISCHAEMIA 25 0.0061
264 PROTEIN TOTAL DECREASED 23 0.0061
265 NECROSIS 34 0.0061
266 CATHETER SITE INFECTION 23 0.0061
267 DISSEMINATED INTRAVASCULAR COAGULATION 85 0.0060
268 LEUKOCYTOSIS 109 0.0060
269 RED CELL DISTRIBUTION WIDTH INCREASED 25 0.0060
270 RECTAL HAEMORRHAGE 258 0.0060
271 LACTIC ACIDOSIS 194 0.0060
272 SKIN NECROSIS 31 0.0060
273 ANAEMIA 1135 0.0059
274 COLITIS 225 0.0059
275 FIBRIN D DIMER INCREASED 21 0.0059
276 PNEUMOCYSTIS JIROVECII PNEUMONIA 59 0.0059
277 ARTERIOSCLEROSIS 55 0.0058
278 OBSTRUCTIVE AIRWAYS DISORDER 65 0.0058
279 LARGE INTESTINE POLYP 40 0.0058
280 CIRCULATORY COLLAPSE 98 0.0057
281 BLOOD PHOSPHORUS DECREASED 21 0.0057
282 NEPHROPATHY TOXIC 64 0.0057
283 ONYCHOMYCOSIS 25 0.0057
284 BACTERIAL INFECTION 106 0.0057
285 PULSE ABSENT 27 0.0057
286 UROSEPSIS 52 0.0056
287 SUPRAVENTRICULAR EXTRASYSTOLES 19 0.0056
288 CUSHINGOID 18 0.0056
289 SWELLING OF EYELID 35 0.0056
290 CLOSTRIDIUM DIFFICILE COLITIS 59 0.0056
291 PARTIAL SEIZURES 29 0.0055
292 BACTERIAL SEPSIS 18 0.0055
293 PROTHROMBIN TIME PROLONGED 33 0.0055
294 SHOCK 126 0.0055
295 ENCEPHALOPATHY 134 0.0055
296 HYPERCALCAEMIA 67 0.0054
297 NEUTROPHIL COUNT DECREASED 220 0.0054
298 VITAMIN D DECREASED 46 0.0054
299 ACUTE PULMONARY OEDEMA 30 0.0053
300 CLOSTRIDIAL INFECTION 18 0.0053
301 HYPERTRANSAMINASAEMIA 37 0.0053
302 ILEUS 66 0.0053
303 PERIPHERAL SENSORY NEUROPATHY 31 0.0053
304 HYPERTRIGLYCERIDAEMIA 31 0.0053
305 DRUG LEVEL INCREASED 87 0.0053
306 RHABDOMYOLYSIS 219 0.0052
307 ACUTE RESPIRATORY FAILURE 101 0.0052
308 RESPIRATORY DEPRESSION 64 0.0052
309 FAILURE TO THRIVE 27 0.0052
310 FLUID INTAKE REDUCED 26 0.0052
311 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 89 0.0052
312 CARDIAC ARREST 428 0.0052
313 DECUBITUS ULCER 42 0.0051
314 SEPSIS 571 0.0051
315 HYPONATRAEMIA 288 0.0051
316 VENOUS THROMBOSIS 20 0.0051
317 PLEURAL EFFUSION 309 0.0051
318 BONE MARROW FAILURE 103 0.0051
319 BRONCHIECTASIS 34 0.0050
320 HYPOXIA 177 0.0050
321 GENERALISED TONIC-CLONIC SEIZURE 83 0.0050
322 HAEMODIALYSIS 42 0.0050
323 TACHYPNOEA 68 0.0050
324 CREATININE RENAL CLEARANCE DECREASED 20 0.0050
325 MENTAL STATUS CHANGES 138 0.0050
326 TOXIC ENCEPHALOPATHY 25 0.0049
327 LEFT VENTRICULAR DYSFUNCTION 33 0.0049
328 RESPIRATORY FAILURE 358 0.0049
329 MUCOSAL INFLAMMATION 128 0.0049
330 HAEMOGLOBIN DECREASED 501 0.0049
331 CARDIOMEGALY 60 0.0049
332 STATUS EPILEPTICUS 55 0.0049
333 PERITONITIS BACTERIAL 49 0.0049
334 BRADYCARDIA 257 0.0048
335 MONOPLEGIA 21 0.0048
336 RALES 28 0.0048
337 FLUID OVERLOAD 70 0.0048
338 PULMONARY HYPERTENSION 100 0.0048
339 LACERATION 45 0.0048
340 C-REACTIVE PROTEIN INCREASED 173 0.0048
341 UNRESPONSIVE TO STIMULI 122 0.0047
342 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 336 0.0047
343 TORSADE DE POINTES 37 0.0047
344 OBESITY 75 0.0047
345 DEVICE RELATED INFECTION 72 0.0047
346 TRANSFUSION 49 0.0047
347 PSEUDOMONAS INFECTION 40 0.0047
348 PERIPHERAL VASCULAR DISORDER 24 0.0047
349 MALNUTRITION 52 0.0046
350 FAECES HARD 18 0.0046
351 RED BLOOD CELL COUNT DECREASED 132 0.0046
352 BLOOD LACTATE DEHYDROGENASE INCREASED 73 0.0046
353 NODULE 60 0.0046
354 DRUG LEVEL ABOVE THERAPEUTIC 21 0.0046
355 HAEMATURIA 157 0.0046
356 ISCHAEMIA 21 0.0046
357 DEPRESSED LEVEL OF CONSCIOUSNESS 178 0.0045
358 ENDOCARDITIS 23 0.0045
359 ATRIOVENTRICULAR BLOCK COMPLETE 30 0.0045
360 BLOOD TRIGLYCERIDES INCREASED 79 0.0045
361 POOR PERIPHERAL CIRCULATION 19 0.0045
362 ATELECTASIS 43 0.0044
363 GRAFT VERSUS HOST DISEASE 32 0.0044
364 ECONOMIC PROBLEM 67 0.0044
365 THROMBOTIC MICROANGIOPATHY 43 0.0044
366 PNEUMONIA ASPIRATION 110 0.0044
367 ULCER 70 0.0044
368 PULMONARY OEDEMA 197 0.0044
369 NEUROTOXICITY 77 0.0044
370 ENTERITIS 28 0.0044
371 HAEMATOCRIT DECREASED 86 0.0043
372 ELECTROCARDIOGRAM ABNORMAL 34 0.0043
373 DUODENAL ULCER PERFORATION 32 0.0043
374 ANURIA 37 0.0043
375 WRONG PRODUCT ADMINISTERED 29 0.0043
376 HYPOTENSION 861 0.0043
377 OVERWEIGHT 23 0.0043
378 CARDIOTOXICITY 38 0.0043
379 PANCYTOPENIA 238 0.0043
380 ELECTROCARDIOGRAM QT PROLONGED 153 0.0042
381 SKIN TIGHTNESS 20 0.0042
382 HEPATIC STEATOSIS 79 0.0042
383 CARDIAC FAILURE CHRONIC 18 0.0042
384 MYOCARDIAL ISCHAEMIA 48 0.0042
385 SUSPECTED OFF LABEL USE 19 0.0042
386 HAEMORRHOIDS 82 0.0042
387 BRAIN INJURY 42 0.0042
388 ENTEROCOLITIS 24 0.0042
389 HEPATIC CYTOLYSIS 53 0.0042
390 POLYURIA 34 0.0041
391 HYPERBILIRUBINAEMIA 43 0.0041
392 HYPERCHOLESTEROLAEMIA 40 0.0041
393 BUNDLE BRANCH BLOCK RIGHT 19 0.0041
394 HYPERGLYCAEMIA 149 0.0041
395 CYTOPENIA 50 0.0041
396 DIVERTICULUM 29 0.0041
397 HAEMATOCHEZIA 225 0.0041
398 WHITE BLOOD CELL COUNT INCREASED 156 0.0041
399 C-REACTIVE PROTEIN ABNORMAL 26 0.0040
400 STAPHYLOCOCCAL SEPSIS 20 0.0040
401 GENERALISED OEDEMA 50 0.0040
402 MALABSORPTION 21 0.0040
403 CLOSTRIDIUM DIFFICILE INFECTION 87 0.0040
404 INJURY 280 0.0040
405 GANGRENE 24 0.0040
406 GASTROENTERITIS 58 0.0040
407 GASTROOESOPHAGEAL REFLUX DISEASE 319 0.0040
408 ORTHOSTATIC HYPOTENSION 69 0.0040
409 BRAIN OEDEMA 50 0.0040
410 JOINT RANGE OF MOTION DECREASED 53 0.0039
411 SHOCK HAEMORRHAGIC 32 0.0039
412 BLOOD POTASSIUM DECREASED 118 0.0039
413 TRICUSPID VALVE INCOMPETENCE 31 0.0039
414 LOW BIRTH WEIGHT BABY 31 0.0039
415 BLOOD BILIRUBIN INCREASED 105 0.0039
416 HAEMOLYSIS 30 0.0039
417 NEURALGIA 94 0.0039
418 THROMBOCYTOPENIA 431 0.0039
419 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 185 0.0038
420 LUNG INFILTRATION 34 0.0038
421 HEPATIC FAILURE 116 0.0038
422 PRESYNCOPE 93 0.0038
423 ASPARTATE AMINOTRANSFERASE INCREASED 203 0.0038
424 AGRANULOCYTOSIS 71 0.0038
425 INFUSION RELATED REACTION 252 0.0038
426 HYPOVOLAEMIC SHOCK 18 0.0038
427 HYPOTHERMIA 38 0.0037
428 PLATELET COUNT DECREASED 400 0.0037
429 OESOPHAGITIS 41 0.0037
430 UPPER GASTROINTESTINAL HAEMORRHAGE 63 0.0037
431 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 28 0.0037
432 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 22 0.0037
433 PNEUMONIA BACTERIAL 34 0.0037
434 LEUKOPENIA 185 0.0037
435 ODYNOPHAGIA 22 0.0037
436 LIVER FUNCTION TEST INCREASED 79 0.0037
437 HYPERTONIA 21 0.0037
438 LOWER GASTROINTESTINAL HAEMORRHAGE 27 0.0036
439 ALANINE AMINOTRANSFERASE INCREASED 224 0.0036
440 INTERNATIONAL NORMALISED RATIO INCREASED 104 0.0036
441 NEPHROTIC SYNDROME 25 0.0036
442 METABOLIC DISORDER 21 0.0036
443 UNEVALUABLE EVENT 271 0.0036
444 TOXICITY TO VARIOUS AGENTS 603 0.0036
445 PULMONARY CONGESTION 47 0.0036
446 SUPRAVENTRICULAR TACHYCARDIA 34 0.0035
447 TASTE DISORDER 72 0.0035
448 MOUTH HAEMORRHAGE 26 0.0035
449 CARDIO-RESPIRATORY ARREST 148 0.0035
450 GRIP STRENGTH DECREASED 31 0.0035
451 STEVENS-JOHNSON SYNDROME 78 0.0035
452 PURPURA 31 0.0035
453 DEHYDRATION 466 0.0035
454 COLITIS ULCERATIVE 156 0.0035
455 LOW DENSITY LIPOPROTEIN INCREASED 27 0.0035
456 HEPATITIS CHOLESTATIC 21 0.0035
457 FOETAL DEATH 18 0.0035
458 FAECALOMA 19 0.0035
459 BASAL CELL CARCINOMA 54 0.0035
460 HYPERTENSION 732 0.0035
461 MITRAL VALVE INCOMPETENCE 39 0.0034
462 GAMMA-GLUTAMYLTRANSFERASE INCREASED 75 0.0034
463 ATRIAL FLUTTER 27 0.0034
464 RESPIRATORY TRACT INFECTION 88 0.0034
465 CONSTIPATION 734 0.0034
466 COMA 160 0.0034
467 IRON DEFICIENCY ANAEMIA 31 0.0034
468 WHEEZING 198 0.0033
469 CARDIAC VALVE DISEASE 19 0.0033
470 OEDEMA PERIPHERAL 405 0.0033
471 ARTERIOSCLEROSIS CORONARY ARTERY 22 0.0033
472 HAEMOGLOBIN ABNORMAL 21 0.0033
473 RHINITIS 26 0.0032
474 COVID-19 PNEUMONIA 38 0.0032
475 GENERAL PHYSICAL HEALTH DETERIORATION 372 0.0032
476 CARDIAC FAILURE 258 0.0032
477 OEDEMA 174 0.0032
478 ASPERGILLUS INFECTION 21 0.0032
479 INTENTIONAL OVERDOSE 205 0.0032
480 PERITONITIS 66 0.0032
481 ATRIAL FIBRILLATION 309 0.0032
482 ESCHERICHIA INFECTION 26 0.0032
483 INCREASED TENDENCY TO BRUISE 29 0.0031
484 LIPASE INCREASED 24 0.0031
485 BLOOD SODIUM DECREASED 59 0.0031
486 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 163 0.0031
487 SMALL INTESTINAL OBSTRUCTION 38 0.0031
488 PNEUMONIA 992 0.0031
489 SUBARACHNOID HAEMORRHAGE 31 0.0030
490 RESPIRATORY RATE INCREASED 27 0.0030
491 BURNING SENSATION 209 0.0030
492 BLOOD ALKALINE PHOSPHATASE INCREASED 74 0.0030
493 PLASMA CELL MYELOMA 116 0.0030
494 RESPIRATORY DISTRESS 82 0.0030
495 ABDOMINAL DISTENSION 310 0.0030
496 TRANSAMINASES INCREASED 66 0.0030
497 IMMUNOSUPPRESSION 26 0.0029
498 PULMONARY HAEMORRHAGE 23 0.0029
499 URINARY RETENTION 98 0.0029
500 HEPATIC FUNCTION ABNORMAL 109 0.0029
501 ECCHYMOSIS 20 0.0029
502 MYELOSUPPRESSION 105 0.0029
503 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 75 0.0029
504 URINARY TRACT INFECTION 496 0.0029
505 CORONARY ARTERY DISEASE 88 0.0029
506 BODY HEIGHT DECREASED 31 0.0029
507 TACHYCARDIA 257 0.0029
508 HYPOGAMMAGLOBULINAEMIA 19 0.0029
509 CARDIAC MURMUR 25 0.0029
510 MIOSIS 23 0.0029
511 PERICARDIAL EFFUSION 66 0.0029
512 PRODUCTIVE COUGH 136 0.0028
513 PYREXIA 985 0.0028
514 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 156 0.0028
515 STAPHYLOCOCCAL INFECTION 93 0.0028
516 HYPOGLYCAEMIA 136 0.0028
517 MOUTH ULCERATION 59 0.0028
518 VENTRICULAR EXTRASYSTOLES 29 0.0028
519 HYPOPHAGIA 71 0.0028
520 WHITE BLOOD CELL COUNT DECREASED 301 0.0028
521 LOWER RESPIRATORY TRACT INFECTION 126 0.0028
522 MYOCLONUS 33 0.0028
523 EJECTION FRACTION DECREASED 43 0.0028
524 VIRAL INFECTION 92 0.0028
525 GASTROINTESTINAL HAEMORRHAGE 230 0.0027
526 DYSPEPSIA 269 0.0027
527 HOSPICE CARE 27 0.0027
528 DIABETES MELLITUS 208 0.0027
529 MYDRIASIS 35 0.0027
530 CARDIOMYOPATHY 40 0.0027
531 BLOOD IRON DECREASED 32 0.0027
532 LIVER INJURY 66 0.0027
533 CHOLELITHIASIS 88 0.0027
534 HEPATIC ENCEPHALOPATHY 25 0.0027
535 BLOOD PRESSURE DECREASED 178 0.0027
536 ALTERED STATE OF CONSCIOUSNESS 58 0.0027
537 THROMBOSIS 214 0.0027
538 SUBDURAL HAEMATOMA 38 0.0027
539 GENERAL PHYSICAL CONDITION ABNORMAL 18 0.0027
540 SPLENOMEGALY 31 0.0026
541 RESPIRATORY SYNCYTIAL VIRUS INFECTION 23 0.0026
542 RESTLESS LEGS SYNDROME 48 0.0026
543 MELAENA 58 0.0026
544 NEUTROPENIA 355 0.0026
545 QUALITY OF LIFE DECREASED 35 0.0026
546 HAEMORRHAGE INTRACRANIAL 39 0.0026
547 SYNOVITIS 47 0.0026
548 DELIRIUM 90 0.0026
549 PULMONARY EMBOLISM 246 0.0026
550 DRUG-INDUCED LIVER INJURY 81 0.0026
551 CELLULITIS 130 0.0026
552 BRONCHOPULMONARY ASPERGILLOSIS 20 0.0026
553 EMOTIONAL DISTRESS 311 0.0026
554 PULMONARY MASS 38 0.0025
555 SEROTONIN SYNDROME 49 0.0025
556 MYOPATHY 22 0.0025
557 CANDIDA INFECTION 43 0.0025
558 ACUTE MYOCARDIAL INFARCTION 75 0.0025
559 MICTURITION URGENCY 29 0.0025
560 INTESTINAL PERFORATION 28 0.0025
561 UPPER RESPIRATORY TRACT INFECTION 115 0.0025
562 FULL BLOOD COUNT DECREASED 50 0.0025
563 ABDOMINAL PAIN 576 0.0025
564 CARDIAC DISORDER 231 0.0025
565 PNEUMONITIS 67 0.0025
566 APHTHOUS ULCER 19 0.0024
567 CARDIAC FAILURE CONGESTIVE 194 0.0024
568 FISTULA 27 0.0024
569 FLUID RETENTION 122 0.0024
570 SKIN ULCER 62 0.0024
571 HEPATOCELLULAR INJURY 34 0.0024
572 LIVE BIRTH 20 0.0024
573 DRUG INTERACTION 379 0.0024
574 GINGIVAL PAIN 19 0.0024
575 BLOOD PRESSURE FLUCTUATION 57 0.0024
576 BLOOD URINE PRESENT 45 0.0024
577 BLOOD CHOLESTEROL INCREASED 110 0.0024
578 VITAMIN D DEFICIENCY 23 0.0024
579 STOMATITIS 143 0.0024
580 FOOT DEFORMITY 26 0.0023
581 CONFUSIONAL STATE 376 0.0023
582 GASTRITIS 61 0.0023
583 DECREASED ACTIVITY 25 0.0023
584 LACRIMATION INCREASED 70 0.0023
585 HAEMATOMA 60 0.0023
586 OSTEOPENIA 35 0.0023
587 LABORATORY TEST ABNORMAL 68 0.0023
588 PLATELET COUNT INCREASED 30 0.0023
589 LIVER DISORDER 102 0.0023
590 PETECHIAE 24 0.0023
591 ACUTE CORONARY SYNDROME 19 0.0023
592 WEIGHT FLUCTUATION 24 0.0023
593 DIARRHOEA 1477 0.0023
594 CHOLECYSTITIS 27 0.0023
595 ASTHMA 256 0.0023
596 OSTEOMYELITIS 41 0.0023
597 BLOOD CREATINE PHOSPHOKINASE INCREASED 65 0.0023
598 WEIGHT DECREASED 628 0.0022
599 CHOLESTASIS 43 0.0022
600 ARRHYTHMIA 105 0.0022
601 SPUTUM DISCOLOURED 21 0.0022
602 BLOOD PRESSURE ABNORMAL 44 0.0022
603 HAEMATEMESIS 56 0.0022
604 PNEUMOTHORAX 35 0.0022
605 BLOOD PRESSURE SYSTOLIC INCREASED 43 0.0022
606 LIVER FUNCTION TEST ABNORMAL 64 0.0022
607 ACUTE HEPATIC FAILURE 30 0.0022
608 FOLLICULITIS 23 0.0022
609 HICCUPS 18 0.0022
610 SKIN LESION 60 0.0022
611 DYSPNOEA EXERTIONAL 82 0.0022
612 DYSURIA 80 0.0022
613 NAIL DISORDER 19 0.0022
614 SWELLING 203 0.0022
615 GRAND MAL CONVULSION 20 0.0022
616 HAEMOPTYSIS 60 0.0021
617 INTERSTITIAL LUNG DISEASE 104 0.0021
618 SEIZURE 247 0.0021
619 DECREASED APPETITE 496 0.0021
620 PALLOR 58 0.0021
621 DRUG TOXICITY 29 0.0021
622 HAEMORRHAGE 222 0.0021
623 GASTROINTESTINAL INFECTION 19 0.0021
624 APHASIA 64 0.0021
625 HEPATOTOXICITY 47 0.0021
626 SCAR 36 0.0021
627 GLYCOSYLATED HAEMOGLOBIN INCREASED 53 0.0021
628 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 20 0.0021
629 IMMUNODEFICIENCY 31 0.0021
630 RED BLOOD CELL SEDIMENTATION RATE INCREASED 23 0.0021
631 TRANSIENT ISCHAEMIC ATTACK 70 0.0021
632 EPISTAXIS 155 0.0021
633 NEPHROLITHIASIS 95 0.0021
634 SLEEP DISORDER 146 0.0021
635 LOCALISED INFECTION 50 0.0021
636 OSTEOPOROSIS 85 0.0021
637 ADRENAL INSUFFICIENCY 25 0.0021
638 PRODUCT PRESCRIBING ERROR 49 0.0021
639 HOSPITALISATION 316 0.0021
640 ACUTE MYELOID LEUKAEMIA 32 0.0021
641 CEREBRAL INFARCTION 50 0.0020
642 VOMITING 960 0.0020
643 KIDNEY INFECTION 40 0.0020
644 INTESTINAL OBSTRUCTION 76 0.0020
645 TENDERNESS 21 0.0020
646 HAEMOLYTIC ANAEMIA 18 0.0020
647 SCIATICA 32 0.0020
648 PULMONARY FIBROSIS 38 0.0020
649 CYSTITIS 63 0.0020
650 OXYGEN SATURATION DECREASED 111 0.0020
651 DEEP VEIN THROMBOSIS 128 0.0020
652 JAUNDICE 53 0.0020
653 PERICARDITIS 33 0.0020
654 BODY TEMPERATURE INCREASED 40 0.0020
655 PANCREATITIS ACUTE 44 0.0020
656 INFUSION SITE PAIN 25 0.0019
657 OFF LABEL USE 1698 0.0019
658 BLOOD PRESSURE INCREASED 294 0.0019
659 DRY MOUTH 156 0.0019
660 DEVICE OCCLUSION 27 0.0019
661 TREATMENT NONCOMPLIANCE 104 0.0019
662 ASTHENIA 713 0.0019
663 INTENTIONAL PRODUCT MISUSE 166 0.0019
664 PANCREATITIS 100 0.0019
665 RASH MACULO-PAPULAR 42 0.0019
666 PREMATURE DELIVERY 30 0.0019
667 PRODUCT ADMINISTRATION ERROR 38 0.0019
668 HEART RATE DECREASED 66 0.0019
669 JOINT STIFFNESS 49 0.0019
670 LUNG INFECTION 29 0.0019
671 DYSPNOEA 1055 0.0019
672 ABDOMINAL PAIN LOWER 47 0.0019
673 IMPAIRED HEALING 61 0.0019
674 HIATUS HERNIA 24 0.0019
675 THERAPY NON-RESPONDER 83 0.0018
676 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 43 0.0018
677 HEMIPARESIS 31 0.0018
678 EYE DISCHARGE 19 0.0018
679 JOINT INJURY 39 0.0018
680 CONDITION AGGRAVATED 555 0.0018
681 CORONARY ARTERY OCCLUSION 25 0.0018
682 LUNG DISORDER 89 0.0018
683 NOCTURIA 22 0.0018
684 RIB FRACTURE 37 0.0018
685 RENAL PAIN 19 0.0018
686 SWELLING FACE 116 0.0018
687 FLATULENCE 101 0.0018
688 LIMB INJURY 48 0.0018
689 WOUND 49 0.0018
690 CEREBRAL HAEMORRHAGE 62 0.0017
691 TYPE 2 DIABETES MELLITUS 58 0.0017
692 POST PROCEDURAL COMPLICATION 33 0.0017
693 GASTROENTERITIS VIRAL 31 0.0017
694 SICKLE CELL ANAEMIA WITH CRISIS 27 0.0017
695 FAECES DISCOLOURED 37 0.0017
696 HEPATIC ENZYME INCREASED 116 0.0017
697 EPILEPSY 52 0.0017
698 ACCIDENTAL OVERDOSE 62 0.0017
699 ABSCESS 27 0.0017
700 GINGIVAL BLEEDING 23 0.0017
701 THIRST 30 0.0017
702 SKIN DISORDER 56 0.0017
703 INFECTION 243 0.0017
704 HAND DEFORMITY 22 0.0017
705 VERTIGO 102 0.0017
706 CONTUSION 161 0.0017
707 SYNCOPE 167 0.0017
708 LETHARGY 96 0.0017
709 DIABETIC KETOACIDOSIS 40 0.0017
710 MYELODYSPLASTIC SYNDROME 24 0.0017
711 CYANOSIS 26 0.0017
712 HEPATIC CIRRHOSIS 31 0.0016
713 HEAD INJURY 52 0.0016
714 HEPATITIS 42 0.0016
715 MUSCLE SPASTICITY 20 0.0016
716 SEASONAL ALLERGY 23 0.0016
717 PAIN 996 0.0016
718 INTENTIONAL PRODUCT USE ISSUE 142 0.0016
719 ANXIETY 461 0.0016
720 DYSSTASIA 47 0.0016
721 BEDRIDDEN 21 0.0016
722 PERIPHERAL SWELLING 246 0.0016
723 DERMATITIS ALLERGIC 20 0.0016
724 MUSCLE RIGIDITY 19 0.0016
725 DIVERTICULITIS 44 0.0016
726 DIABETES MELLITUS INADEQUATE CONTROL 28 0.0016
727 SYSTEMIC LUPUS ERYTHEMATOSUS 56 0.0016
728 SWOLLEN TONGUE 49 0.0016
729 SINUS DISORDER 31 0.0016
730 BONE DENSITY DECREASED 49 0.0016
731 AGEUSIA 39 0.0016
732 RESTLESSNESS 57 0.0016
733 URINARY INCONTINENCE 46 0.0016
734 EOSINOPHILIA 27 0.0015
735 IMPAIRED GASTRIC EMPTYING 21 0.0015
736 DISEASE PROGRESSION 181 0.0015
737 NAUSEA 1210 0.0015
738 BRONCHITIS 113 0.0015
739 CONTRAINDICATED PRODUCT ADMINISTERED 46 0.0015
740 INCREASED APPETITE 29 0.0015
741 HALLUCINATION, VISUAL 32 0.0015
742 ADVERSE REACTION 20 0.0015
743 INSURANCE ISSUE 23 0.0015
744 FUNGAL INFECTION 50 0.0015
745 HERPES ZOSTER 86 0.0015
746 DRUG INTOLERANCE 144 0.0015
747 LYMPHOMA 23 0.0015
748 OSTEOARTHRITIS 63 0.0015
749 AGITATION 109 0.0015
750 DRUG RESISTANCE 38 0.0015
751 LOSS OF CONSCIOUSNESS 189 0.0015
752 GASTRIC ULCER 28 0.0015
753 PRODUCT USE IN UNAPPROVED INDICATION 365 0.0015
754 MATERNAL EXPOSURE DURING PREGNANCY 131 0.0015
755 LYMPHADENOPATHY 52 0.0015
756 ANGINA PECTORIS 42 0.0015
757 MOVEMENT DISORDER 47 0.0015
758 HIP FRACTURE 47 0.0015
759 CARDIOVASCULAR DISORDER 37 0.0015
760 FALL 481 0.0014
761 CHILLS 169 0.0014
762 MEDICATION ERROR 80 0.0014
763 GLOSSODYNIA 32 0.0014
764 SYRINGE ISSUE 25 0.0014
765 NIGHT SWEATS 46 0.0014
766 FOOT FRACTURE 27 0.0014
767 MALAISE 623 0.0014
768 ERYTHEMA 291 0.0014
769 POLLAKIURIA 59 0.0014
770 DRUG ERUPTION 25 0.0014
771 GASTROINTESTINAL DISORDER 126 0.0014
772 ISCHAEMIC STROKE 25 0.0014
773 OVERDOSE 302 0.0014
774 NEUROPATHY PERIPHERAL 133 0.0014
775 PARALYSIS 20 0.0014
776 COVID-19 244 0.0014
777 INFLUENZA 155 0.0014
778 ORAL PAIN 31 0.0014
779 EXPOSURE DURING PREGNANCY 86 0.0014
780 CHEST PAIN 256 0.0014
781 DYSARTHRIA 52 0.0014
782 RESPIRATORY ARREST 38 0.0014
783 COMPLICATION ASSOCIATED WITH DEVICE 20 0.0014
784 PRODUCT PRESCRIBING ISSUE 30 0.0014
785 GAIT INABILITY 46 0.0014
786 CEREBROVASCULAR ACCIDENT 233 0.0014
787 HEADACHE 861 0.0014
788 RESPIRATORY DISORDER 41 0.0014
789 MUSCULOSKELETAL STIFFNESS 120 0.0014
790 PREMATURE BABY 41 0.0014
791 PRODUCT USE ISSUE 255 0.0014
792 DEPRESSION 306 0.0013
793 RASH PAPULAR 30 0.0013
794 TREMOR 221 0.0013
795 PHOTOPHOBIA 25 0.0013
796 TOOTHACHE 24 0.0013
797 HEART RATE INCREASED 131 0.0013
798 BLISTER 74 0.0013
799 NERVOUS SYSTEM DISORDER 41 0.0013
800 HYPOKINESIA 19 0.0013
801 MYOCARDIAL INFARCTION 225 0.0013
802 MUSCULAR WEAKNESS 146 0.0013
803 DYSPHONIA 75 0.0013
804 PSORIATIC ARTHROPATHY 52 0.0013
805 BACK PAIN 297 0.0013
806 MULTIPLE FRACTURES 21 0.0013
807 COLON CANCER 19 0.0013
808 RASH PRURITIC 69 0.0013
809 SOMNOLENCE 255 0.0013
810 RETCHING 27 0.0013
811 DISORIENTATION 50 0.0013
812 BRONCHOSPASM 18 0.0013
813 DRUG INEFFECTIVE 1662 0.0013
814 PRESCRIBED UNDERDOSE 25 0.0013
815 IMPAIRED QUALITY OF LIFE 18 0.0013
816 DEATH 1076 0.0012
817 FATIGUE 971 0.0012
818 CHROMATURIA 28 0.0012
819 EAR INFECTION 33 0.0012
820 COUGH 347 0.0012
821 ABDOMINAL DISCOMFORT 206 0.0012
822 FEELING COLD 34 0.0012
823 HYPERSOMNIA 35 0.0012
824 CHEST DISCOMFORT 124 0.0012
825 BLOOD GLUCOSE INCREASED 228 0.0012
826 THERAPEUTIC PRODUCT EFFECT DECREASED 54 0.0012
827 ARTHRITIS 94 0.0012
828 ABDOMINAL PAIN UPPER 245 0.0012
829 BLOOD COUNT ABNORMAL 18 0.0012
830 FEEDING DISORDER 24 0.0012
831 MOBILITY DECREASED 85 0.0012
832 INFLAMMATION 61 0.0012
833 DEMENTIA 33 0.0012
834 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 84 0.0012
835 DRUG DISPENSING ERROR 18 0.0012
836 MUSCLE SPASMS 215 0.0012
837 MUSCLE TWITCHING 27 0.0012
838 DYSGEUSIA 87 0.0012
839 TINNITUS 53 0.0012
840 SKIN DISCOLOURATION 53 0.0012
841 BONE DISORDER 21 0.0012
842 BLOOD GLUCOSE DECREASED 55 0.0011
843 NECK PAIN 64 0.0011
844 GAIT DISTURBANCE 219 0.0011
845 INTERVERTEBRAL DISC PROTRUSION 25 0.0011
846 ADVERSE EVENT 105 0.0011
847 CONVULSION 65 0.0011
848 ABASIA 28 0.0011
849 CONJUNCTIVITIS 21 0.0011
850 DYSKINESIA 46 0.0011
851 NASOPHARYNGITIS 208 0.0011
852 FACE OEDEMA 19 0.0011
853 SUICIDE ATTEMPT 68 0.0011
854 DISABILITY 22 0.0011
855 CATARACT 66 0.0011
856 FEMUR FRACTURE 34 0.0011
857 HYPOAESTHESIA 164 0.0011
858 ILL-DEFINED DISORDER 66 0.0011
859 EATING DISORDER 23 0.0011
860 HYPERHIDROSIS 139 0.0011
861 IMPAIRED WORK ABILITY 23 0.0011
862 MEMORY IMPAIRMENT 147 0.0011
863 DIZZINESS 532 0.0011
864 DISCOMFORT 65 0.0011
865 GALLBLADDER DISORDER 19 0.0011
866 PAIN IN EXTREMITY 312 0.0011
867 MYALGIA 179 0.0011
868 MUSCULOSKELETAL PAIN 55 0.0010
869 ANAPHYLACTIC REACTION 58 0.0010
870 DYSPHAGIA 99 0.0010
871 OROPHARYNGEAL PAIN 96 0.0010
872 TOOTH DISORDER 23 0.0010
873 PRESCRIBED OVERDOSE 20 0.0010
874 FOETAL EXPOSURE DURING PREGNANCY 84 0.0010
875 HEAD DISCOMFORT 18 0.0010
876 RASH GENERALISED 26 0.0010
877 THROAT TIGHTNESS 27 0.0010
878 MENTAL IMPAIRMENT 24 0.0010
879 PAIN IN JAW 28 0.0010
880 MALIGNANT NEOPLASM PROGRESSION 101 0.0010
881 PRODUCT DOSE OMISSION 64 0.0010
882 POOR QUALITY SLEEP 21 0.0010
883 PRODUCT PREPARATION ERROR 20 0.0010
884 TOOTH LOSS 20 0.0010
885 DRUG DOSE OMISSION 159 0.0010
886 PARAESTHESIA 151 0.0010
887 WEIGHT INCREASED 214 0.0010
888 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 172 0.0010
889 UPPER LIMB FRACTURE 19 0.0010
890 NASAL CONGESTION 56 0.0010
891 INSOMNIA 253 0.0009
892 GLAUCOMA 18 0.0009
893 ANAPHYLACTIC SHOCK 24 0.0009
894 HALLUCINATION 70 0.0009
895 BALANCE DISORDER 80 0.0009
896 ILLNESS 95 0.0009
897 EYE PAIN 52 0.0009
898 EMOTIONAL DISORDER 28 0.0009
899 PRODUCT DOSE OMISSION ISSUE 267 0.0009
900 SINUSITIS 93 0.0009
901 DERMATITIS 19 0.0009
902 HYPOACUSIS 39 0.0009
903 ANGIOEDEMA 40 0.0009
904 PRURITUS 347 0.0009
905 RASH ERYTHEMATOUS 43 0.0009
906 THERAPEUTIC RESPONSE DECREASED 54 0.0009
907 JOINT SWELLING 107 0.0009
908 HEART RATE IRREGULAR 20 0.0009
909 RHINORRHOEA 57 0.0009
910 DRUG ADMINISTRATION ERROR 27 0.0009
911 THERAPY CESSATION 45 0.0009
912 ABORTION SPONTANEOUS 34 0.0008
913 FEELING HOT 52 0.0008
914 RASH 368 0.0008
915 INTENTIONAL DOSE OMISSION 24 0.0008
916 BONE PAIN 49 0.0008
917 SURGERY 49 0.0008
918 RASH MACULAR 29 0.0008
919 DRUG ABUSE 69 0.0008
920 PALPITATIONS 97 0.0008
921 PANIC ATTACK 30 0.0008
922 DISEASE RECURRENCE 39 0.0008
923 LIP SWELLING 27 0.0008
924 PROSTATE CANCER 65 0.0008
925 ECZEMA 41 0.0008
926 HYPERSENSITIVITY 144 0.0008
927 ARTHRALGIA 318 0.0008
928 THERAPY INTERRUPTED 53 0.0007
929 MENTAL DISORDER 32 0.0007
930 OSTEONECROSIS 24 0.0007
931 NERVOUSNESS 38 0.0007
932 SKIN EXFOLIATION 61 0.0007
933 ARTHROPATHY 40 0.0007
934 LIMB DISCOMFORT 22 0.0007
935 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
936 DEPRESSED MOOD 37 0.0007
937 MOOD ALTERED 19 0.0007
938 VISUAL ACUITY REDUCED 23 0.0007
939 MIGRAINE 66 0.0007
940 VISUAL IMPAIRMENT 85 0.0007
941 VISION BLURRED 94 0.0007
942 EYE PRURITUS 23 0.0007
943 OCULAR HYPERAEMIA 32 0.0007
944 SPEECH DISORDER 35 0.0007
945 COGNITIVE DISORDER 31 0.0007
946 NEOPLASM PROGRESSION 23 0.0007
947 HOT FLUSH 49 0.0006
948 DEVICE LEAKAGE 28 0.0006
949 GASTRIC DISORDER 22 0.0006
950 TREATMENT FAILURE 53 0.0006
951 FLUSHING 65 0.0006
952 NIGHTMARE 22 0.0006
953 FEELING ABNORMAL 151 0.0006
954 EYE IRRITATION 36 0.0006
955 DRY SKIN 83 0.0006
956 DRY EYE 31 0.0006
957 EYE DISORDER 20 0.0006
958 IRRITABILITY 36 0.0006
959 EYE SWELLING 22 0.0006
960 BLINDNESS 24 0.0006
961 COMPLETED SUICIDE 49 0.0006
962 URTICARIA 96 0.0006
963 UNDERDOSE 41 0.0006
964 LUNG NEOPLASM MALIGNANT 23 0.0006
965 THROAT IRRITATION 25 0.0006
966 ADVERSE DRUG REACTION 50 0.0006
967 INCORRECT DOSE ADMINISTERED 127 0.0006
968 AMNESIA 35 0.0005
969 DRUG EFFECT INCOMPLETE 19 0.0005
970 AGGRESSION 26 0.0005
971 DEVICE BREAKAGE 21 0.0005
972 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
973 ABNORMAL BEHAVIOUR 20 0.0005
974 NO ADVERSE EVENT 91 0.0005
975 ALOPECIA 96 0.0005
976 PRODUCT QUALITY ISSUE 66 0.0005
977 DEVICE DISLOCATION 21 0.0005
978 DISTURBANCE IN ATTENTION 26 0.0005
979 DEVICE ISSUE 43 0.0005
980 VAGINAL HAEMORRHAGE 20 0.0005
981 INFLUENZA LIKE ILLNESS 34 0.0004
982 INJECTION SITE ERYTHEMA 51 0.0004
983 DRUG EFFECT DECREASED 22 0.0004
984 INJECTION SITE PAIN 121 0.0004
985 NEOPLASM MALIGNANT 26 0.0004
986 RHEUMATOID ARTHRITIS 44 0.0004
987 INJECTION SITE HAEMORRHAGE 30 0.0004
988 PSORIASIS 48 0.0004
989 INJECTION SITE REACTION 25 0.0004
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 71 0.0004
991 DEVICE MALFUNCTION 24 0.0003
992 ACNE 25 0.0003
993 INJECTION SITE SWELLING 24 0.0003
994 INJECTION SITE BRUISING 22 0.0003
995 DRUG DEPENDENCE 26 0.0002